Form D — Cue Biopharma, Inc.
0001645460-26-000003 · filed 2026-05-14
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $29,999,992
- Total sold
- $29,999,992
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Cue Biopharma, Inc.
- CIK
- 1645460
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 40 GUEST STREET
BOSTON, MA 02135 - Phone
- 617-949-2680
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Shao-Lee Lin · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Colin Sandercock · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Daniel Baker · Executive OfficerBoston, MA Find on LinkedIn ↗
-
Pasha Sarraf · DirectorBoston, MA Find on LinkedIn ↗
-
Frank Morich · DirectorBoston, MA Find on LinkedIn ↗
-
Peter Kiener · DirectorBoston, MA Find on LinkedIn ↗
-
Patrick Verheyen · DirectorBoston, MA Find on LinkedIn ↗
-
Pamela D. Garzone · DirectorBoston, MA Find on LinkedIn ↗
-
Jill M. Broadfoot · DirectorBoston, MA Find on LinkedIn ↗
View original on SEC EDGAR.